Table 4. Predictors of retention and mortality post ART initiation.
| Mortality | Loss to Follow-up or Dead | ||||
|---|---|---|---|---|---|
| †Variable | n | Unadjusted HR (95% CL) | ħAdjusted HR (95% CL) | Unadjusted HR (95% CL) | ħAdjusted HR (95% CL) |
| Aged ≥50 vs. <50 | 22582 | 1.58 (1.42, 1.76) | 1.35 (1.19, 1.52) | 0.83 (0.78, 0.87) | 0.83 (0.78, 0.87) |
| Male | 22582 | 2.09 (1.92, 1.28) | 1.90 (1.72, 2.09) | 1.08 (1.03, 1.12) | 1.08 (1.03, 1.12) |
| Urban clinic location | 22582 | 0.82 (0.75, 0.90) | 0.74 (0.68, 0.82) | 0.99 (0.95, 1.03) | 0.99 (0.95, 1.03) |
| Married | 22454 | 0.82 (0.75, 0.89) | 0.74 (0.67, 0.81) | 0.85 (0.82, 0.88) | 0.85 (0.82, 0.88) |
| §Using OI prophylaxis | 21025 | 1.36 (1.24, 1.49) | 1.22 (1.11, 1.34) | 1.34 (1.29, 1.39) | 1.34 (1.29, 1.39) |
| Advanced HIV status | 21873 | 3.37 (1.04, 3.74) | 3.07 (2.74, 3.45) | 1.08 (1.05, 1.13) | 1.08 (1.05, 1.13) |
| ₮Hospitalized | 21937 | 1.43 (1.25, 1.65) | 1.39 (1.20, 1.60) | 0.80 (0.75, 0.86) | 0.80 (0.75, 0.86) |
| §Disclosed HIV status | 22386 | 1.28 (1.16, 1.42) | 1.25 (1.12, 1.40) | 0.98 (0.94, 1.02) | 0.98 (0.94, 1.02) |
| Sample size | 19708 | 19708 | |||
†Variables measured at enrollment, Advanced HIV status = CD4 < 200 cells / mm3 or WHO clinical stage 3 or 4.
₮Hospitalized during follow-up.
§At baseline.
ħWeighted for missing data on CD4, WHO clinical stage, and BMI, HR–Hazard Ratio, 95% CL: 95% Confidence Limits.